Apellis Pharmaceuticals, Inc. Stock, NASDAQ:APLS
100 Fifth Avenue, Suite A, Waltham, Massachusetts 02451
United States of America
Number of Employees: 235
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.